SCHEMBL5202737

SCHEMBL5202737

CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1/N=N/C1C(=O)N(c2ccc(C)c(C)c2)N=C1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.50
▸ ALDH1A1 P00352 5/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ NPC1 O15118 3/20 0.50
▸ LMNA P02545 3/20 0.50
▸ TDP1 Q9NUW8 3/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ MEN1 O00255 8/20 0.48
▸ KMT2A Q03164 8/20 0.48
▸ EP300 Q09472 1/20 0.46
▸ POLB P06746 3/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ GAA P10253 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5206340 1.00 MAPT (0.50) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL5206330 1.00 MAPT (0.50) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL5206134 0.90 MEN1 (0.51) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL5206139 0.90 MEN1 (0.51) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL5206131 0.90 MEN1 (0.51) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL5204074 0.88 MAPT (0.52) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL5204078 0.88 MAPT (0.52) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL7165995 0.86 MAPT (0.48) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL7165988 0.86 MAPT (0.48) MAPTALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL7165991 0.86 MAPT (0.48) MAPTALDH1A1SMN1; SMN2NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1223944-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2007-01-03 — — EP claimed
US-6552008-B1 Administering effective amount of a selected azo-pyrazole derivative for therapy of thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-04-22 — — US claimed
EP-1223944-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2007-01-03 — — EP disclosed
US-6552008-B1 Administering effective amount of a selected azo-pyrazole derivative for therapy of thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-04-22 — — US disclosed
Send feedback